🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

23 results for “BioNTech Manufacturing GmbH” Clear

  1. BNT323, Ribodoxo® 2 mg/ml Injektionslösung, DOCETAXEL , Paclitaxel AqVida 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung

    BioNTech Manufacturing GmbH

    Endometrial cancer

    phase 3 small molecule active

    1 trial

  2. PACLITAXEL , BNT327, PEMETREXED , CARBOPLATIN , BNT327, PEMBROLIZUMAB

    BioNTech Manufacturing GmbH

    Non-small cell lung cancer

    phase 3 small molecule active

    1 trial

  3. PACLITAXEL , GEMCITABINE , CARBOPLATIN , BNT327, Abraxane 5 mg/ml powder for dispersion for infusion., ERIBULIN , BNT327 Placebo

    BioNTech Manufacturing GmbH

    First line triple-negative breast cancer (TNBC)

    phase 3 small molecule active

    1 trial

  4. PEMBROLIZUMAB , BNT113

    BioNTech Manufacturing GmbH

    Unresectable head and neck squamous cell carcinoma, metastatic head and neck cancer, recurrent head and neck cancer

    phase 3 small molecule active

    1 trial

  5. Tecentriq 1 200 mg concentrate for solution for infusion, CISPLATIN , CARBOPLATIN , BNT327, ETOPOSIDE

    BioNTech Manufacturing GmbH

    English First-line extensive-stage small-cell lung cancer (ES-SCLC)

    phase 3 small molecule active

    1 trial

  6. BNT111, LIBTAYO 350 mg concentrate for solution for infusion.

    BioNTech Manufacturing GmbH

    Melanoma (Stage III and IV)

    phase 2 small molecule active

    1 trial

  7. BNT142

    BioNTech Manufacturing GmbH

    Solid Tumors

    phase 2 small molecule active

    1 trial

  8. BNT327 1-15, BNT327, BNT326

    BioNTech Manufacturing GmbH

    Advanced solid tumors

    phase 2 small molecule active

    1 trial

  9. BNT327, BNT314, BNT327 1-15

    BioNTech Manufacturing GmbH

    Metastatic colorectal cancer

    phase 2 small molecule active

    1 trial

  10. BNT327, BNT323

    BioNTech Manufacturing GmbH

    Advanced Breast Cancer Metastatic Breast Cancer

    phase 2 small molecule active

    1 trial

  11. BNT327, BNT324

    BioNTech Manufacturing GmbH

    Advanced Lung Cancer

    phase 2 small molecule active

    1 trial

  12. BNT327, DOCETAXEL

    BioNTech Manufacturing GmbH

    Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  13. BNT329

    BioNTech Manufacturing GmbH

    Advanced Solid Cancers

    phase 2 small molecule active

    1 trial

  14. Calciumfolinat HEXAL 10 mg/ml Injektionslösung, Irinotecan HCl AqVida 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung, BNT321, FLUOROURACIL, Oxaliplatin AqVida 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung

    BioNTech Manufacturing GmbH

    Resected (R0 or R1) pancreatic ductal adenocarcinoma

    phase 2 small molecule active

    1 trial

  15. PACLITAXEL , BNT326, CARBOPLATIN , BNT327, PEMBROLIZUMAB , PEMETREXED

    BioNTech Manufacturing GmbH

    Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  16. Watchful waiting, RO7198457 (autogene cevumeran)

    BioNTech Manufacturing GmbH

    Stage II/Stage III rectal cancer or Stage II (high risk)/Stage III colon cancer

    phase 2 small molecule active

    1 trial

  17. A clinical trial investigating the safety and biological activity of the antibody BNT351 in adults living without and with HIV

    BioNTech Manufacturing GmbH

    HIV-1 infection

    phase 1 other active

    1 trial

  18. An open-label Phase 1 study of NEO-PTC-01 in patients with advanced or metastatic melanoma

    BioNTech Manufacturing GmbH

    Metastatic melanoma

    phase 1 other active

    1 trial

  19. BNT211, BNT211, BNT211, BNT211

    BioNTech Manufacturing GmbH

    Solid Tumors

    phase 1 small molecule active

    1 trial

  20. BNT314

    BioNTech Manufacturing GmbH

    Advanced or metastatic malignant solid tumors

    phase 1 small molecule active

    1 trial

  21. Clinical trial evaluating the safety, tolerability, and preliminary efficacy of BNT116 alone and in combinations in patients with advanced non-small cell lung cancer

    BioNTech Manufacturing GmbH

    Advanced non-small cell lung cancer

    phase 1 other active

    1 trial

  22. Dose escalation trial of BNT152+153 in patients with cancer

    BioNTech Manufacturing GmbH

    Various solid tumors that are metastatic or unresectable

    phase 1 other active

    1 trial

  23. Safety and immune responses after vaccination with two investigational RNA-based vaccines against tuberculosis in healthy volunteers

    BioNTech Manufacturing GmbH

    Tuberculosis

    phase 1 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources